Recombinant Human Thymosin Beta 4 Injection (NL005)

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Recombinant Human Thymosin Beta 4 Injection (NL005)
Treatment and conditionWhere it standsTrials
Recombinant Human Thymosin Beta 4 Injection (NL005) for anterior wall myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Recombinant Human Thymosin Beta 4 Injection (NL005) for st elevation myocardial infarctionTrial registered, as of 19 Nov 2026 (not yet checked by a person)1